1. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. 1998; Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 25:1991–4. PMID:
9779856.
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. 2004; International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 31:390–2. PMID:
14760812.
3. Thierry S, Fautrel B, Lemelle I, Guillemin F. 2014; Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 81:112–7. DOI:
10.1016/j.jbspin.2013.09.003. PMID:
24210707.
4. Bowyer S, Roettcher P. 1996; Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol. 23:1968–74. PMID:
8923377.
5. Rosenberg AM. 2005; Longitudinal analysis of a pediatric rheumatology clinic population. J Rheumatol. 32:1992–2001. PMID:
16206357.
6. Arkachaisri T, Tang SP, Daengsuwan T, Phongsamart G, Vilaiyuk S, Charuvanij S, et al. 2017; Paediatric rheumatology clinic population in Southeast Asia: are we different? Rheumatology (Oxford). 56:390–8. DOI:
10.1093/rheumatology/kew446. PMID:
27994096.
7. Al-Mayouf SM, Al Mutairi M, Bouayed K, Habjoka S, Hadef D, Lotfy HM, et al. 2021; Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. Pediatr Rheumatol Online J. 19:166. DOI:
10.1186/s12969-021-00650-x. PMID:
34857004. PMCID:
PMC8638433.
8. Giancane G, Muratore V, Marzetti V, Quilis N, Benavente BS, Bagnasco F, et al. 2019; Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 21:168. DOI:
10.1186/s13075-019-1950-7. PMID:
31287015. PMCID:
PMC6615271.
10. Donabedian A. 1966; Evaluating the quality of medical care. Milbank Mem Fund Q. 44((3):Suppl):166–206. DOI:
10.2307/3348969. PMID:
5338568.
11. Institute of Medicine. 2001. Crossing the quality chasm: a new health system for the 21st century. National Academy Press;Washington, DC:
12. Lovell DJ, Passo MH, Beukelman T, Bowyer SL, Gottlieb BS, Henrickson M, et al. 2011; Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 63:10–6. DOI:
10.1002/acr.20348. PMID:
20842714. PMCID:
PMC3016458.
13. Barber CEH, Twilt M, Pham T, Currie GR, Benseler S, Yeung RSM, et al. 2020; A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care. Arthritis Res Ther. 22:53. DOI:
10.1186/s13075-020-02151-w. PMID:
32192528. PMCID:
PMC7083048.
14. McErlane F, Foster HE, Armitt G, Bailey K, Cobb J, Davidson JE, et al. 2018; Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership. Rheumatology (Oxford). 57:140–51. DOI:
10.1093/rheumatology/kex322. PMID:
29069424. PMCID:
PMC5850477.
15. McErlane F, Anderson C, Lawson-Tovey S, Lee B, Lee C, Lunt L, et al. 2022; Quality improvement in juvenile idiopathic arthritis: a mixed-methods implementation pilot of the CAPTURE-JIA dataset. Pediatr Rheumatol Online J. 20:43. DOI:
10.1186/s12969-022-00697-4. PMID:
35717328. PMCID:
PMC9206126.
16. Passo MH, Taylor J. 2008; Quality improvement in pediatric rheumatology: what do we need to do? Curr Opin Rheumatol. 20:625–30. DOI:
10.1097/BOR.0b013e32830c690f. PMID:
18698189.
18. Scott C, Chan M, Slamang W, Okong'o L, Petty R, Laxer RM, et al. 2019; Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind. Clin Rheumatol. 38:563–75. DOI:
10.1007/s10067-018-4304-y. PMID:
30267356.
19. Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019; 2019 American College of Rheumatology/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Rheumatol. 71:846–63. DOI:
10.1002/art.40884. PMID:
31021537. PMCID:
PMC6561114.
20. Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, et al. 2022; 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Arthritis Rheumatol. 74:570–85. DOI:
10.1002/art.42036. PMID:
35233961. PMCID:
PMC10127939.
21. Onel KB, Horton DB, Lovell DJ, Shenoi S, Cuello CA, Angeles-Han ST, et al. 2022; 2021 American College of Rheumatology guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 74:553–69. DOI:
10.1002/art.42037. PMID:
35233993. PMCID:
PMC10161784.
22. Munro J, Murray K, Boros C, Chaitow J, Allen RC, Akikusa J, et al. 2014; Australian Paediatric Rheumatology Group standards of care for the management of juvenile idiopathic arthritis. J Paediatr Child Health. 50:663–6. DOI:
10.1111/jpc.12462. PMID:
25156704.
23. Davies K, Cleary G, Foster H, Hutchinson E, Baildam E. 2010; BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis. Rheumatology (Oxford). 49:1406–8. DOI:
10.1093/rheumatology/kep460. PMID:
20173199.
24. Cooper SM, Currie GR, Kromm S, Twilt M, Marshall DA. 2023; Evaluating key performance indicators of the process of care in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 21:37. DOI:
10.1186/s12969-023-00818-7. PMID:
37085775. PMCID:
PMC10120096.
25. El Tal T, Ryan ME, Feldman BM, Bingham CA, Burnham JM, Batthish M, et al. 2022; Consensus approach to a treat-to-target strategy in juvenile idiopathic arthritis care: report from the 2020 PR-COIN consensus conference. J Rheumatol. 49:497–503. DOI:
10.3899/jrheum.210709. PMID:
35105705.
26. Alkwai HM, Mirza A, Abdwani R, Asiri A, Bakry R, Alenazi A, et al. 2021; Consensus clinical approach for a newly diagnosed systemic juvenile idiopathic arthritis among members of the pediatric rheumatology Arab group. Int J Pediatr Adolesc Med. 8:129–33. DOI:
10.1016/j.ijpam.2021.05.003. PMID:
34350323. PMCID:
PMC8319680.
27. Oommen PT, Strauss T, Baltruschat K, Foeldvari I, Deuter C, Ganser G, et al. 2022; Update of evidence- and consensus-based guidelines for the treatment of juvenile idiopathic arthritis (JIA) by the German Society of Pediatric and Juvenile Rheumatic Diseases (GKJR): new perspectives on interdisciplinary care. Clin Immunol. 245:109143. DOI:
10.1016/j.clim.2022.109143. PMID:
36191738.
28. El Miedany Y, Salah S, Lotfy H, El Gaafary M, Abdulhady H, Salah H, et al. 2022; Updated clinical practice treat-to-target guidelines for JIA management: the Egyptian College of Pediatric Rheumatology initiative. Egypt Rheumatol Rehabil. 49:27. DOI:
10.1186/s43166-022-00125-1.